Jeremy Rich was named deputy director of research at UPMC Hillman Cancer Center.
Rich will also serve as the Pittsburgh Foundation Chair in Personalized Cancer Therapy and a professor of neurology at the University of Pittsburgh School of Medicine. Rich will help oversee Hillman’s strategic cancer research efforts.
Rich is a board-certified neuro-oncologist and physician-scientist specializing in diagnosing and treating brain tumors, with a focus on brain metastases. He is also a brain tumor biology researcher, studying cancer stem cell clinical relevance and how they interact with the tumor microenvironment to help the cancers grow and resist current treatments.
Previously, Rich was a professor of medicine, director of the Brain Tumor Institute and co-director of the Solid Tumor Therapeutics Program at the University of California San Diego. Before that, he was chair of the Department of Stem Cell Biology and Regenerative Medicine at Cleveland Clinic.
